Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ondansetron Hydrochloride and Sodium Chloride Injection

Approval Number

国药准字H20040650

Company江苏豪森药业集团有限公司

Registration Date

June 30, 2020

Drug Information

Generic Name

盐酸昂丹司琼氯化钠注射液

Trade Name

维泽

Brand Name

维泽

Dosage Form

注射剂

Strength

100ml:昂丹司琼8mg与氯化钠0.9g

Drug Type

化学药品

Registration Date

June 30, 2020

Company Information

Applicant Company

Company Name江苏豪森药业集团有限公司

Company Address

江苏省连云港经济技术开发区

Manufacturing Company

Company Name江苏豪森药业集团有限公司

Company Address

连云港经济技术开发区庐山路8号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy